Literature DB >> 9741927

Nasal delivery of peptides: an in vitro cell culture model for the investigation of transport and metabolism in human nasal epithelium.

T Kissel1, U Werner.   

Abstract

We investigated the transport- and metabolism properties of three peptides in monolayers of human nasal epithelial cells. The effective permeability coefficients of thyrotropin-releasing hormone, met-enkephalin and human recombinant insulin were found to be 4.5, 4.4 and 0.4 x 10(-7) cm/s, respectively. The permeability was inversely proportional to the molecular weight and one order of magnitude lower than in excised nasal mucosa of rabbits. The metabolic cleavage of thyrotropin-releasing hormone (TRH) to the free acid by cytosolic prolyl-endopeptidase was also detected in human nasal cell monolayers, suggesting that ca. 10% of the total amount of TRH is transported via a transcellular pathway. Met-enkephalin is a substrate for aminopeptidases, located on the apical membrane of nasal epithelial cells. Metabolites and enzyme activity are comparable with literature data. Our studies demonstrate that not only morphological, but also functional properties of human nasal epithelial cells are preserved under in vitro conditions. Such a cell culture model based on human nasal cells could be beneficial for the characterization of peptide transport on a cellular level and for investigation of the absorption enhancer mechanism. Further studies are necessary, however, to establish correlations between in vitro permeabilities in cell cultures and nasal drug absorption in animals and humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9741927     DOI: 10.1016/s0168-3659(97)00253-8

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  14 in total

Review 1.  Absorption enhancers for nasal drug delivery.

Authors:  Stanley S Davis; Lisbeth Illum
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Evidence for LHRH-receptor expression in human airway epithelial (Calu-3) cells and its role in the transport of an LHRH agonist.

Authors:  Kavitha Koushik; Nagesh Bandi; Sneha Sundaram; Uday B Kompella
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

Review 3.  Nasal route and drug delivery systems.

Authors:  Selcan Türker; Erten Onur; Yekta Ozer
Journal:  Pharm World Sci       Date:  2004-06

4.  Intranasal delivery--modification of drug metabolism and brain disposition.

Authors:  Yin Cheong Wong; Zhong Zuo
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

5.  Assessment of nasal spray deposition pattern in a silicone human nose model using a color-based method.

Authors:  Vipra Kundoor; Richard N Dalby
Journal:  Pharm Res       Date:  2009-11-10       Impact factor: 4.200

6.  Retinoic acid and hydrocortisone strengthen the barrier function of human RPMI 2650 cells, a model for nasal epithelial permeability.

Authors:  Levente Kürti; Szilvia Veszelka; Alexandra Bocsik; Béla Ozsvári; László G Puskás; Agnes Kittel; Piroska Szabó-Révész; Mária A Deli
Journal:  Cytotechnology       Date:  2012-09-02       Impact factor: 2.058

7.  Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity.

Authors:  Pamela T Wong; Su He Wang; Susan Ciotti; Paul E Makidon; Douglas M Smith; Yongyi Fan; Charles F Schuler; James R Baker
Journal:  Mol Pharm       Date:  2013-12-13       Impact factor: 4.939

8.  Spray-dried mucoadhesive microspheres: preparation and transport through nasal cell monolayer.

Authors:  Saraporn Harikarnpakdee; Vimolmas Lipipun; Narueporn Sutanthavibul; Garnpimol C Ritthidej
Journal:  AAPS PharmSciTech       Date:  2006-02-10       Impact factor: 3.246

9.  Permeation studies of indomethacin from different emulsions for nasal delivery and their possible anti-inflammatory effects.

Authors:  H Yeşim Karasulu; Z Evren Sanal; Sumru Sözer; Tamer Güneri; Gökhan Ertan
Journal:  AAPS PharmSciTech       Date:  2008-02-14       Impact factor: 3.246

Review 10.  Attenuation of kindled seizures by intranasal delivery of neuropeptide-loaded nanoparticles.

Authors:  Michael J Kubek; Abraham J Domb; Michael C Veronesi
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.